Inquiry Basket
Cat No.: BADC-02020
4.5 
DEDN6526A is an antibody-drug conjugate (ADC) composed of a humanized IgG1 monoclonal antibody against anti-endothelin B receptor (ETBR) and the tubulin inhibitor monomethyl auristatin E (MMAE). DEDN6526A was developed for the treatment of Metastatic or Unresectable Melanoma.
* For research and manufacturing use only. We do not sell to patients.
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
Popular Publications Citing BOC Sciences Products
DEDN6526A
Required fields are marked with *
DEDN6526A
Required fields are marked with *
Contact our experts today for pricing and comprehensive details on our ADC offerings.
From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.
Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.
Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.
